Results 41 to 50 of about 38,180 (186)
Factor V Leiden and Thromboembolism [PDF]
Circulation, 1998 To the Editor: In an excellent study, Ridker et al1 recently demonstrated that the risk of thrombosis is greatly increased when the factor V Leiden mutation and hyperhomocysteinemia, which alone are only moderate risk factors for thrombosis, occur together.
Michael Walter +4 more
openaire +1 more source
Factor V Leiden Mutation and Neonatal Stroke
Pediatric Neurology Briefs, 1997 Three infants with familial factor V Leiden mutation and neonatal cerebrovascular disorders are reported from the Children’s Hospital of Philadelphia, PA.
J Gordon Millichap
doaj +1 more source
Factor V Leiden and Natural Selection [PDF]
Clinical and Applied Thrombosis/Hemostasis, 2011 [No abstract available]
openaire +3 more sources
Frequency of factor V Leiden (G1691A) and prothrombin (G20210A) polymorphisms in Population of Kerman Province, Iran [PDF]
Journal of Kerman University of Medical Sciences, 2017 Background & Aims:Thromboembolism is an acute cardiovascular disease that ranges from clinically unimportant to massive embolism. Both acquired and hereditary risk factors contribute to the disease.
Nasrollah Saleh-gohari +1 more
doaj
Fator V de Leiden na doença de Legg-Calvé-Perthes Leiden's V-factor in Legg-Calvé-Perthes disease
Acta Ortopédica Brasileira, 2009 Trobofilias hereditárias têm sido implicadas na patogênese da doenca de Legg-Calvé-Perthes. Uma investigação do fator de risco hereditário mais comum para hipercoagulabilidade - a mutação no gene do fator V (fator V de Leiden) - foi conduzida em 20 ...
Lia Lira Olivier Sanders +5 more
doaj +1 more source
Research and Practice in Thrombosis and Haemostasis, 2020 Combined oral contraceptives and factor V Leiden mutation are multiplicative risk factors for venous thromboembolism. However, it remains unknown whether this multiplicative effect is reflected in thrombin generation assays.
Maxime G. Zermatten +3 more
doaj +1 more source
FV Leiden mutation and deep venous thrombosis in Vojvodina: A case-control study [PDF]
Journal of Medical Biochemistry, 2011 Between September 2007 and February 2010, the occurrence of symptomatic deep venous thrombosis (DVT) was investigated in a cohort of 79 consecutive patients. A case-control study included 71 healthy controls matched with cases for sex and age.
Salatić Iva +4 more
doaj
BMC Medical Genetics, 2019 Background Preeclampsia can lead to adverse maternal and perinatal outcomes. There are few studies on the association of preeclampsia with thrombophilia in Africa including Sudan.
Nadir A. Ahmed +4 more
doaj +1 more source
Journal of Community Hospital Internal Medicine Perspectives, 2019 It is well documented that factor V Leiden mutation (FVL) is a common hypercoagulable risk factor in the Caucasian population. Patients with homozygous FVL mutation have an increased risk for venous thromboembolism.
Hadiatou Barry +2 more
doaj +1 more source
Advances in Hematology, 2020 Objectives. Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms characterized by a sustained elevation of platelet numbers with a tendency for thrombosis and hemorrhage.
Mohamed S. El-Ghonemy +5 more
doaj +1 more source